The metabolic syndrome in obese postmenopausal women: Relationship to body composition, visceral fat, and inflammation

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5517-5522

  You, Tongjian ^a   Ryan, Alice S ^b   Nicklas, Barbara J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADIPOCYTE; ADULT; AEROBIC CAPACITY; AGE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FITNESS; HUMAN; HUMAN TISSUE; INFLAMMATION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; ORGAN DISTRIBUTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; FEMALE; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POSTMENOPAUSE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; VISCERA;

EID: 8744221620     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0480     Document Type: Article

References (49)

1. Ley CJ, Lees B, Stevenson JC 1992 Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 55:950-954
2. Zamboni M, Armellini F, Harris T, Turcato E, Micciolo R, Bergamo-Andreis IA, Bosello O 1997 Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 66:111-115
3. Tchernof A, Poehlman ET 1998 Effects of the menopause transition on body fatness and body fat distribution. Obes Res 6:246-254
4. Bjorntorp P 1990 "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496
5. Kissebah A, Krakower G 1998 Regional adiposity and morbidity. Physiol Rev 74:761-811
6. Despres JP 1998 The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patient's risk. Obes Res 6:8S-17S
7. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, Sellers TA, Lazovich D, Prineas RJ 2000 Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med 160:2117-2128
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
9. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359
10. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB 2003 The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163:427-436
11. Bertoli A, Di Daniele N, Ceccobelli M, Ficara A, Girasoli C, De Lorenzo A 2003 Lipid profile, BMI, body fat distribution, and aerobic fitness in men with metabolic syndrome. Acta Diabetol 40:S130-S133
12. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET 2001 What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86:1020-1025
13. Chan JC, Cheung JC, Stehouwer CD, Emeis JJ, Tong PC, Ko GT, Yudkin JS 2002 The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome: an analysis by structural equation modelling. Int J Obes Relat Metab Disord 26:994-1008
14. Forouhi NG, Sattar N, McKeigue PM 2001 Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 25:1327-1331
15. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W 2000 Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23:1835-1839
16. Garaulet M, Perez-Llamas F, Zamora S, Tebar FJ 2002 Interrelationship between serum lipid profile, serum hormones and other components of the metabolic syndrome. J Physiol Biochem 58:151-160
17. Carroll S, Cooke CB, Butterly RJ 2000 Metabolic clustering, physical activity and fitness in nonsmoking, middle-aged men. Med Sci Sports Exerc 32:2079-2086
18. Wareham NJ, Hennings SJ, Byrne CD, Hales CN, Prentice AM, Day NE 1998 A quantitative analysis of the relationship between habitual energy expenditure, fitness and the metabolic cardiovascular syndrome. Br J Nutr 80:235-241
19. Ridker PM, Buring JE, Cook NR, Rifai N 2003 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107:391-397
20. Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H, Murata C, Otsuka R, Zhu S, Toyoshima H 2003 The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 2:443-449
21. Nicklas BJ, Rogus EM, Colman EG, Goldberg AP 1996 Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women. Am J Physiol 270:E72-E78
22. Dole VP 1956 A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest 35:150-154
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
24. Solini A, Bonora E, Bonadonna R, Castellino P, DeFronzo RA 1997 Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue. J Clin Endocrinol Metab 82:2552-2558
25. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH 1983 Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 57:304-310
26. Leenen R, van der Kooy K, Seidell JC, Deurenberg P, Koppeschaar HP 1994 Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 78:1515-1520
27. Berman DM, Rodrigues LM, Nicklas BJ, Ryan AS, Dennis KE, Goldberg AP 2001 Racial disparities in metabolism, central obesity, and sex hormone-binding globulin in postmenopausal women. J Clin Endocrinol Metab 86:97-103
28. Ferrannini E, Barrett EJ, Bevilacqua S, Jacob R, Walesky M, Sherwin RS, DeFronzo RA 1986 Effect of free fatty acids on blood amino acid levels in human. Am J Physiol 250:E686-E694
29. Keller U, Turkalj I, Laager R, Bloesch D, Bilz S 2002 Effects of medium- and long-chain fatty acids on whole body leucine and glucose kinetics in man. Metabolism 51:754-760
30. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C 1987 Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80:415-424
31. Carroll S, Cooke CB, Butterly RJ 2000 Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness. Blood Coagul Fibrinolysis 11:71-78
32. Imbeault P, Lemieux S, Prud'homme D, Tremblay A, Nadeau A, Despres JP, Mauriege P 1999 Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy? Metabolism 48:355-362
33. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE 2000 Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498-1506
34. Fried SK, Bunkin DA, Greenberg AS 1998 Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850
35. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM 1995 Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415
36. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B 2002 Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87:2084-2089
37. Bullo-Bonet M, Garcia-Lorda P, Lopez-Soriano FJ, Argiles JM, Salas-Salvado J 1999 Tumour necrosis factor, a key role in obesity? FEBS Lett 451:215-219
38. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V 2000 Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214
39. Pickup JC, Mattock MB, Chusney GD, Burt D 1997 NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292
40. Kishimoto T, Akira S, Taga T 1992 Interleukin-6 and its receptor: a paradigm for cytokines. Science 258:593-597
41. Grell M 1995 Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflamm 47:8-17
42. Aderka D 1996 The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7:231-240
43. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM 2001 The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15:43-58
44. Fernandez-Real JM, Gutierrez C, Ricart W, Castineira MJ, Vendrell J, Richart C 1999 Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects. Atherosclerosis 146:321-327
45. Fernandez-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C 1998 Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47:1757-1762
46. Dzienis-Straczkowska S, Straczkowski M, Szelachowska M, Stepien A, Kowalska I, Kinalska I 2003 Soluble tumor necrosis factor-α receptors in young obese subjects with normal and impaired glucose tolerance. Diabetes Care 26:875-880
47. Hauner H, Bender M, Haastert B, Hube F 1998 Plasma concentrations of soluble TNF-α receptors in obese subjects. Int J Obes Relat Metab Disord 22:1239-1243
48. Hube F, Hauner H 1999 The role of TNF-α inhuman adipose tissue: prevention of weight gain at the expense of insulin resistance? Horm Metab Res 31:626-631
49. Hube F, Birgel M, Lee YM, Hauner H 1999 Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 29:672-678